Antiepileptic treatment in pregnant women: Morphological and behavioural effects

Handbook of Experimental Pharmacology

Volumn 205, Issue , 2011, Pages 295-315

  Tomson, Torbjörn ^a   Battino, Dina ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Antiepileptic drugs; Congenital malformations; Epilepsy; Pregnancy; Teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PRIMIDONE; VALPROIC ACID;

ARTICLE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONGENITAL MALFORMATION; DRUG DOSE COMPARISON; EPILEPSY; FETUS RISK; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; OBSERVATIONAL STUDY; PERINATAL DRUG EXPOSURE; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEIZURE; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; CASE-CONTROL STUDIES; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TERATOGENS;

EID: 80054961464     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-20195-0_15     Document Type: Article

References (106)

1. Adab N, Jacoby A, Smith D et al (2001) Additional educational needs in children born to motherswith epilepsy. J Neurol Neurosurg Psychiatry 70:15-21 (Pubitemid 32096115)
2. Adab N, Kini U, Vinten J et al (2004a) The longer term outcome of children born to mothers withepilepsy. J Neurol Neurosurg Psychiatry 75:1575-1583 (Pubitemid 39430610)
3. Adab N, Tudur SC, Vinten J et al (2004b) Common antiepileptic drugs in pregnancy in womenwith epilepsy (Cochrane Review) The Cochrane Library. Wiley, Chichester
4. Amore BM, Kalhorn TF, Skiles GL et al (1997) Characterization of carbamazepine metabolism ina mouse model of carbamazepine teratogenicity. Drug Metab Dispos 25:953-962 (Pubitemid 27357693)
5. Artama M, Auvinen A, Raudaskoski T et al (2005) Antiepileptic drug use of women with epilepsyand congenital malformations in offspring. Neurology 64:1874-1878 (Pubitemid 40800700)
6. Azarbayjani F, Danielsson BR (2002) Embryonic arrhythmia by inhibition of HERG channels: Acommon hypoxia-related teratogenic mechanism for antiepileptic drugs? Epilepsia43:457-468 (Pubitemid 34533700)
7. Battino D, Tomson T (2007) Management of epilepsy during pregnancy. Drugs 67:2727-2746 (Pubitemid 350224382)
8. Battino D, Granata T, Binelli S et al (1992) Intrauterine growth in the offspring of epilepticmothers. Acta Neurol Scand 86:555-557
9. Battino D, Kaneko S, Andermann E et al (1999) Intrauterine growth in the offspring of epilepticwomen: A prospective multicenter study. Epilepsy Res 36:53-60 (Pubitemid 29363015)
10. Bennett GD, Amore BM, Finnell RH et al (1996) Teratogenicity of carbamazepine-10, 11-epoxideand oxcarbazepine in the SWV mouse. J Pharmacol Exp Ther 279:1237-1242 (Pubitemid 27166770)
11. Bittigau P, Sifringer M, Genz K et al (2002) Antiepileptic drugs and apoptotic neurodegenerationin the developing brain. Proc Natl Acad Sci USA 99:15089-15094 (Pubitemid 35334614)
12. Buehler BA, Delimont D, van Waes M et al (1990) Prenatal prediction of risk of the fetalhydantoin syndrome. N Engl J Med 322:1567-1572 (Pubitemid 20176697)
13. Buehler BA, Rao V, Finnell RH (1994) Biochemical and molecular teratology of fetal hydantoinsyndrome. Neurol Clin 12:741-748 (Pubitemid 24349490)
14. Canger R, Battino D, Canevini MP et al (1999) Malformations in offspring of women withepilepsy: A prospective study. Epilepsia 40:1231-1236 (Pubitemid 29416391)
15. Choulika S, Harvey E, Holmes LB (1999) Effect of antiepileptic drugs (AED) on fetal growth:assessment at birth. Teratology 59:388
16. Cunnington M, Ferber S, Quartey G (2007) Effect of dose on the frequency of major birth defectsfollowing fetal exposure to lamotrigine monotherapy in an international observational study.Epilepsia 48:1207-1210 (Pubitemid 46854869)
17. Danielsson B, Skold AC, Azarbayjani F et al (2000) Pharmacokinetic data support pharmacologicallyinduced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.Toxicol Appl Pharmacol 163:164-175 (Pubitemid 30152091)
18. Dansky LV, Andermann E, Rosenblatt D et al (1987) Anticonvulsants, folate levels, and pregnancyoutcome: A prospective study. Ann Neurol 21:176-182 (Pubitemid 17016832)
19. Dean JC, Moore SJ, Osborne A et al (1999) Fetal anticonvulsant syndrome and mutation in thematernal MTHFR gene. Clin Genet 56:216-220 (Pubitemid 29494820)
20. Dean JC, Hailey H, Moore SJ et al (2002) Long term health and neurodevelopment in childrenexposed to antiepileptic drugs before birth. J Med Genet 39:251-259 (Pubitemid 34496801)
21. Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ et al (2001) Association of prenatal phenobarbitaland phenytoin exposure with genital anomalies and menstrual disorders. Teratology64:181-188 (Pubitemid 32904936)
22. Dolk H, Jentink J, Loane Met al (2008) Does lamotrigine use in pregnancy increase orofacial cleftrisk relative to other malformations? Neurology 71:714-722
23. Eriksson K, Viinikainen K, Monkkonen A et al (2005) Children exposed to valproate in uteropopulationbased evaluation of risks and confounding factors for long-term neurocognitivedevelopment. Epilepsy Res 65:189-200 (Pubitemid 41187573)
24. Finnell RH (1991) Genetic differences in susceptibility to anticonvulsant drug-induced developmentaldefects. Pharmacol Toxicol 69:223-227
25. Finnell RH, Dansky LV (1991) Parental epilepsy, anticonvulsant drugs, and reproductive outcome:epidemiologic and experimental findings spanning three decades; 1: Animal studies.Reprod Toxicol 5:281-299
26. Finnell RH, Bennett GD, Slattery JT et al (1995) Effect of treatment with phenobarbitaland stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.Teratology 52:324-332 (Pubitemid 26080522)
27. Fonager K, Larsen H, Pedersen L et al (2000) Birth outcomes in women exposed to anticonvulsantdrugs. Acta Neurol Scand 101:289-294 (Pubitemid 30249531)
28. Fried S, Kozer E, Nulman I et al (2004) Malformation rates in children of women with untreatedepilepsy: A meta-analysis. Drug Saf 27:197-202 (Pubitemid 38315328)
29. Gaily E (1991) Development and growth in children of epileptic mothers. A prospective controlledstudy. Acta Obstet Gynecol Scand 70:631-632
30. Gaily E, Granstrom ML, Hiilesmaa V et al (1988) Minor anomalies in offspring of epilepticmothers. J Pediatr 112:520-529
31. Gaily E, Kantola-Sorsa E, Granstrom ML (1990) Specific cognitive dysfunction in children withepileptic mothers. Dev Med Child Neurol 32:403-414 (Pubitemid 20179601)
32. Gaily E, Kantola-Sorsa E, Hiilesmaa V et al (2004) Normal intelligence in children with prenatalexposure to carbamazepine. Neurology 62:28-32 (Pubitemid 38082865)
33. German J, Ehlers KH, Kowal A et al (1970) Possible teratogenicity of trimethadione andparamethadione. Lancet 2:261-262
34. Hanson JW, Myrianthopoulos NC, Harvey MA et al (1976) Risks to the offspring of womentreated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.J Pediatr 89:662-668
35. Harden CL, Meador KJ, Pennell PB et al (2009) Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes:report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommitteeof the American Academy of Neurology and the American Epilepsy Society. Epilepsia50:1237-1246
36. Hernandez-Diaz S, Smith CR, Wyszynski DF et al (2007) Risk of major malformations amonginfants exposed to carbamazepine during pregnancy. Birth Def Res 79:357
37. Hiilesmaa VK, Teramo K, Granstrom ML et al (1981) Fetal head growth retardation associatedwith maternal antiepileptic drugs. Lancet 2:165-167 (Pubitemid 11085401)
38. Holmes LB, Rosenberger PB, Harvey EA et al (2000) Intelligence and physical features ofchildren of women with epilepsy. Teratology 61:196-202 (Pubitemid 30130823)
39. Holmes LB, Harvey EA, Coull BA et al (2001) The teratogenicity of anticonvulsant drugs. N EnglJ Med 344:1132-1138 (Pubitemid 32285234)
40. Holmes LB, Wyszynski DF, Lieberman E (2004) The AED (antiepileptic drug) pregnancyregistry: A 6-year experience. Arch Neurol 61:673-678 (Pubitemid 38637683)
41. Holmes LB, Baldwin EJ, Smith CR et al (2008a) Increased frequency of isolated cleft palate ininfants exposed to lamotrigine during pregnancy. Neurology 70:2152-2158
42. Holmes LB, Smith CR, Herndandez-Diaz S (2008b) Pregnancy registries: Larger sample sizesessential. Birth Def Res A 82:307
43. Hunt S, Craig J, Russell A et al (2006) Levetiracetam in pregnancy: Preliminary experience fromthe UK Epilepsy and Pregnancy Register. Neurology 67:1876-1879 (Pubitemid 44900776)
44. Hunt S, Russell A, Smithson WH et al (2008) Topiramate in pregnancy: Preliminary experiencefrom the UK Epilepsy and Pregnancy Register. Neurology 71:272-276
45. Hvas CL, Henriksen TB, Ostergaard JR et al (2000) Epilepsy and pregnancy: Effect of antiepilepticdrugs and lifestyle on birthweight. BJOG 107:896-902 (Pubitemid 30417347)
46. Kaaja E, Kaaja R, Hiilesmaa V (2003) Major malformations in offspring of women with epilepsy.Neurology 60:575-579 (Pubitemid 36246072)
47. Kallen AJ (1994) Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8:203-205 (Pubitemid 2096052)
48. Kaneko S, Battino D, Andermann E et al (1999) Congenital malformations due to antiepilepticdrugs. Epilepsy Res 33:145-158
49. Kini U, Adab N, Vinten J et al (2006) Dysmorphic features: An important clue to the diagnosis andseverity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 91:F90-F95 (Pubitemid 43325524)
50. Kjaer D, Horvath-Puho E, Christensen J et al (2007) Use of phenytoin, phenobarbital, or diazepamduring pregnancy and risk of congenital abnormalities: A case-time-control study. PharmacoepidemiolDrug Saf 16:181-188 (Pubitemid 46291170)
51. Kluger BM, Meador KJ (2008) Teratogenicity of antiepileptic medications. Semin Neurol28:328-335
52. Kondo T, Kaneko S, Amano Y et al (1996) Preliminary report on teratogenic effects of zonisamidein the offspring of treated women with epilepsy. Epilepsia 37:1242-1244 (Pubitemid 26415248)
53. Lillibridge JH, Amore BM, Slattery JT et al (1996) Protein-reactive metabolites of carbamazepinein mouse liver microsomes. Drug Metab Dispos 24:509-514 (Pubitemid 26143770)
54. Lindhout D, Omtzigt JG (1992) Pregnancy and the risk of teratogenicity. Epilepsia 33:S41-S48
55. Lindhout D, Schmidt D (1986) In-utero exposure to valproate and neural tube defects. Lancet1:1392-1393 (Pubitemid 16121930)
56. Lindhout D, Hoppener RJ, Meinardi H (1984) Teratogenicity of antiepileptic drug combinationswith special emphasis on epoxidation (of carbamazepine). Epilepsia 25:77-83 (Pubitemid 14195325)
57. Long L (2003) Levetiracetam monotherapy during pregnancy: A case series. Epilepsy Behav4:447-448 (Pubitemid 37038802)
58. Malm H, Kajantie E, Kivirikko S et al (2002) Valproate embryopathy in three sets of siblings:further proof of hereditary susceptibility. Neurology 59:630-633 (Pubitemid 34920006)
59. Martz F, Failinger C 3rd, Blake DA (1977) Phenytoin teratogenesis: Correlation betweenembryopathic effect and covalent binding of putative arene oxide metabolite in gestationaltissue. J Pharmacol Exp Ther 203:231-239 (Pubitemid 8203905)
60. Meador K, Reynolds MW, Crean S et al (2008) Pregnancy outcomes in women with epilepsy: Asystematic review and meta-analysis of published pregnancy registries and cohorts. EpilepsyRes 81:1-13
61. Meador KJ, Baker GA, Browning N et al (2009) Cognitive function at 3 years of age after fetalexposure to antiepileptic drugs. N Engl J Med 360:1597-1605
62. Meadow SR (1968) Anticonvulsant drugs and congenital abnormalities. Lancet 2:1296
63. Meischenguiser R, D'Giano CH, Ferraro SM (2004) Oxcarbazepine in pregnancy: Clinical experiencein Argentina. Epilepsy Behav 5:163-167 (Pubitemid 38461205)
64. Montouris G (2003) Gabapentin exposure in human pregnancy: Results from the GabapentinPregnancy Registry. Epilepsy Behav 4:310-317 (Pubitemid 37203308)
65. Moore SJ, Turnpenny P, Quinn A et al (2000) A clinical study of 57 children with fetal anticonvulsantsyndromes. J Med Genet 37:489-497 (Pubitemid 30428234)
66. Morrow J, Russell A, Guthrie E et al (2006) Malformation risks of antiepileptic drugs inpregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. J NeurolNeurosurg Psychiatry 77:193-198 (Pubitemid 43220841)
67. Morrow JI, Hunt SJ, Russell AJ et al (2009) Folic acid use and major congenital malformations inoffspring of women with epilepsy: A prospective study from the UK Epilepsy and PregnancyRegister. J Neurol Neurosurg Psychiatry 80:506-511
68. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: Results of theMedical Research Council Vitamin Study [see comments]. Lancet 338:131-137
69. Ogawa Y, Kaneko S, Otani K et al (1991) Serum folic acid levels in epileptic mothers and theirrelationship to congenital malformations. Epilepsy Res 8:75-78
70. Ornoy A, Zvi N, Arnon J et al (2008) The outcome of pregnancy following topiramate treatment: Astudy on 52 pregnancies. Reprod Toxicol 25:388-389
71. Pantarotto C, Arboix M, Sezzano P et al (1982) Studies on 5,5-diphenylhydantoin irreversiblebinding to rat liver microsomal proteins. Biochem Pharmacol 31:1501-1507 (Pubitemid 12161765)
72. Parman T, Chen G, Wells PG (1998) Free radical intermediates of phenytoin and relatedteratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonancespectrometry, and photochemical product analysis. J Biol Chem 273:25079-25088 (Pubitemid 28443265)
73. Perucca E, Tomson T (2006) Prenatal exposure to antiepileptic drugs. Lancet 367:1467-1469
74. Puho EH, Szunyogh M, Metneki J et al (2007) Drug treatment during pregnancy and isolatedorofacial clefts in Hungary. Cleft Palate Craniofac J 44:194-202 (Pubitemid 46417591)
75. Rane A, Peng D (1985) Phenytoin enhances epoxide metabolism in human fetal liver cultures.Drug Metab Dispos 13:382-385 (Pubitemid 15009462)
76. Rasalam AD, Hailey H, Williams JH et al (2005) Characteristics of fetal anticonvulsant syndromeassociated autistic disorder. Dev Med Child Neurol 47:551-555 (Pubitemid 41131614)
77. Raymond GV, Buehler BA, Finnell RH et al (1995) Anticonvulsant teratogenesis: 3. Possiblemetabolic basis. Teratology 51:55-56
78. Registry SMB http://www.janusinfo.org/. Accessed 2009
79. Rosa FW (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy.N Engl J Med 324:674-677
80. Roy D, Snodgrass WR (1990) Covalent binding of phenytoin to protein and modulation ofphenytoin metabolism by thiols in A/J mouse liver microsomes. J Pharmacol Exp Ther252:895-900 (Pubitemid 20127388)
81. Samrén EB, van Duijn CM, Koch S et al (1997) Maternal use of antiepileptic drugs and the risk ofmajor congenital malformations: A joint European prospective study of human teratogenesisassociated with maternal epilepsy. Epilepsia 38:981-990 (Pubitemid 27382935)
82. Samrén EB, van Duijn CM, Christiaens GC et al (1999) Antiepileptic drug regimens and majorcongenital abnormalities in the offspring. Ann Neurol 46:739-746 (Pubitemid 29518135)
83. Scolnik D, Nulman I, Rovet J et al (1994) Neurodevelopment of children exposed in utero tophenytoin and carbamazepine monotherapy. JAMA 271:767-770 (Pubitemid 24074524)
84. Speidel BD, Meadow SR (1972) Maternal epilepsy and abnormalities of fetus and the newborn.Lancet 2:839-843
85. Spina E, Perugi G (2004) Antiepileptic drugs: Indications other than epilepsy. Epileptic Disord6:57-75 (Pubitemid 38808120)
86. Strickler SM, Dansky LV, Miller MA et al (1985) Genetic predisposition to phenytoin-inducedbirth defects. Lancet 2:746-749
87. ten Berg K, Samrén EB, van Oppen AC et al (2005) Levetiracetam use and pregnancy outcome.Reprod Toxicol 20:175-178 (Pubitemid 40459666)
88. Thomas SV, Ajaykumar B, Sindhu K et al (2008) Motor and mental development of infantsexposed to antiepileptic drugs in utero. Epilepsy Behav 13:229-236
89. Tomson T, Battino D (2005) Teratogenicity of antiepileptic drugs: State of the art. Curr OpinNeurol 18:135-140 (Pubitemid 40477488)
90. Tomson T, Battino D (2009) The management of epilepsy in pregnancy. In: Shorvon S, Pedley TA(eds) The epilepsies 3: Blue books of neurology. Saunders Elsevier, Philadelphia, pp 241-264
91. Tomson T, Hiilesmaa V (2007) Epilepsy in pregnancy. BMJ 335:769-773 (Pubitemid 47612634)
92. Tomson T, Beghi E, Sundqvist A et al (2004a) Medical risks in epilepsy: A review with focus onphysical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 60:1-16 (Pubitemid 38981756)
93. Tomson T, Perucca E, Battino D (2004b) Navigating toward fetal and maternal health: Thechallenge of treating epilepsy in pregnancy. Epilepsia 45:1171-1175 (Pubitemid 39350328)
94. Tomson T, Battino D, Craig J et al (2010) Pregnancy registries: Differences, similarities, andpossible harmonization. Report of a working group of the Commission on TherapeuticStrategies of the International League Against Epilepsy. Epilepsia 51:909-915
95. Vajda FJ, Hitchcock A, Graham J et al (2007) The Australian Register of Antiepileptic Drugs inPregnancy: The first 1002 pregnancies. Aust N Z J Obstet Gynaecol 47:468-474 (Pubitemid 350075922)
96. Veiby G, Daltveit AK, Engelsen BA et al (2009) Pregnancy, delivery, and outcome for the child inmaternal epilepsy. Epilepsia 50:2130-2139
97. Viinikainen K, Heinonen S, Eriksson K et al (2006) Community-based, prospective, controlledstudy of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia47:186-192
98. Vinten J, Adab N, Kini U et al (2005) Neuropsychological effects of exposure to anticonvulsantmedication in utero. Neurology 64:949-954 (Pubitemid 40388441)
99. Volcik KA, Shaw GM, Lammer EJ et al (2003) Evaluation of infant methylenetetrahydrofolatereductase genotype, maternal vitamin use, and risk of high versus low level spina bifidadefects. Birth Defects Res A Clin Mol Teratol 67:154-157 (Pubitemid 37238055)
100. Wells PG, Winn LM (1996) Biochemical toxicology of chemical teratogenesis. Crit Rev BiochemMol Biol 31:1-40 (Pubitemid 26076456)
101. Wells PG, Kim PM, Laposa RR et al (1997) Oxidative damage in chemical teratogenesis. MutatRes 396:65-78 (Pubitemid 28012643)
102. Wide K, Winbladh B, Tomson T et al (2000) Body dimensions of infants exposed to antiepilepticdrugs in utero: Observations spanning 25 years. Epilepsia 41:854-861 (Pubitemid 30439577)
103. Wide K, Henning E, Tomson T et al (2002) Psychomotor development in preschool childrenexposed to antiepileptic drugs in utero. Acta Paediatr 91:409-414 (Pubitemid 34478193)
104. Wide K, Winbladh B, Kallen B (2004) Major malformations in infants exposed to antiepilepticdrugs in utero, with emphasis on carbamazepine and valproic acid: A nation-wide, populationbasedregister study. Acta Paediatr 93:174-176 (Pubitemid 38230710)
105. Wyszynski DF, Nambisan M, Surve T et al (2005) Increased rate of major malformations inoffspring exposed to valproate during pregnancy. Neurology 64:961-965 (Pubitemid 40388443)
106. Zhu H, Kartiko S, Finnell RH (2009) Importance of gene-environment interactions in the etiologyof selected birth defects. Clin Genet 75:409-423